NexGen Energy Stock (NYSE:NXE), Trade Ideas

NexGen Energy

NexGen Energy Ltd is a mineral exploration company. It is engaged in the acquisition, exploration, evaluation and development of uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin. The Rook I property hosts the world-class Arrow Zone, the Bow discovery. as well as the discovered Harpoon area located northeast of the Arrow deposit.

News

Small Cap

Markets

ETFs

BWXT

Nuveen Arizona Dividend Advantage Municipal Funds 3

UUUU

The global shift towards clean energy sources has intensified the search for reliable and scalable alternatives to fossil fuels. While the solar and wind power sectors have captured significant attention, a renewed interest in nuclear energy is emerging.

Why These Nuclear Stocks Could Beat Solar and Wind Energy Stocks

Penny Stocks

Intraday Update

Movers

Trading Ideas

ALLG

BLDP

CMPS

DOMA

DOYU

IREN

JZXN

MESO

OUST

SMXT

TCOM

ZIMV

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.

Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday

Uranyl,Nitrate,Or,Uranium,Is,A,Yellow,Water-soluble,Uranium,Salt

Commodities

CURUF

FCUUF

ISENF

LURAF

NTELF

SASKF

SRUUF

As governments increasingly reconsider nuclear energy as a solution to growing climate change concerns, uranium prices have surged.

Uranium Surge Revives Old Mines, Sparks Mergers Across Sector

NexGen Energy Ltd

NEXIEN BIOPHARMA INC by Nexien BioPharma, Inc.

Nexien BioPharma Inc

NXERA PHARMA CO LTD by Nxera Pharma Co.,Ltd.

Nxera Pharma Co Ltd

The global shift towards clean energy sources has intensified the search for reliable and scalable alternatives to fossil fuels. While the solar and wind power sectors&nbsp;have captured significant attention, a renewed interest in nuclear energy is emerging. Nuclear power, with its potential for consistent baseload generation, small footprint (particularly with newer technologies), and improving safety profile, holds the potential to outperform traditional renewables in specific contexts.
Could nuclear energy stocks be the key to outperforming the broader renewable energy market in the long run?&nbsp;
<h2>Unleashing the Power of the Atom: Uranium Miners</h2>
Uranium, the foundational element of nuclear power, will become an increasingly valuable commodity in the coming years. If the push for clean energy fuels a nuclear resurgence, uranium mining companies will be positioned at the forefront of this transition. Let&#39;s look at some of the key players in this subsector of the mining sector:
<h3>Cameco Corporation&nbsp;</h3>
Cameco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccj#NYSE">CCJ</a>), a global giant in uranium production, stands out for its extensive reserves and established track record in the industry. Ranked among the world&#39;s leading uranium producers, Cameco&#39;s expertise and substantial reserves in Canada make it a significant player in the global uranium market.
<h3>Denison Mines</h3>
Denison Mines&nbsp;(AMEX:DNN)&nbsp;is committed to environmentally conscious mining operations. The company is actively involved in exploration and development projects within the Athabasca Basin region of Canada, which is renowned for its abundance of uranium resources. Denison prioritizes environmentally responsible mining practices and holds a diverse portfolio of projects, including exploration and development assets in this uranium-rich region of Canada.
<h3>Energy Fuels</h3>
Energy Fuels (AMEX:UUUU), a US-based mining company, has diversified operations that encompass uranium, vanadium, and rare earth element recovery. This multifaceted approach positions Energy Fuels to capitalize on various critical material needs. Notably, beyond uranium, Energy Fuels engages in the recovery of vanadium and rare earth elements. This unique combination makes them an intriguing player as demand for these materials evolves.
<h3>NexGen Energy</h3>
NexGen Energy&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) claim to fame is the high-grade Arrow Deposit, a substantial uranium resource located in Canada&#39;s Athabasca Basin. The quality of this deposit and its projected long mine life make NexGen a company to watch. Additionally, NexGen boasts a relatively low expected production cost, which could improve its profitability if uranium prices surge. The company is also exploring the possibility of using innovative in-situ recovery (ISR) mining techniques, further differentiating its approach.
Uranium miners face unique risks, such as fluctuating commodity prices and the potential for regulatory changes that could impact their operations. However, if the anticipated surge in nuclear power demand materializes, these companies could potentially deliver substantial returns for investors.
<h2>The Next Generation: Reactor Developers</h2>
While traditional nuclear power plants have proven their capabilities, they often come with large capital costs, lengthy construction timelines, and a degree of public anxiety. A wave of innovative companies are tackling these challenges by developing new reactor technologies that promise greater safety, scalability, and potential cost advantages. Let&#39;s examine a few key players in this space:
<h3>NuScale Power&nbsp;</h3>
NuScale Power (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) pioneered small modular reactor (SMR) technology. Unlike traditional plants, SMRs are designed to be smaller, factory-built units that can be deployed more quickly and potentially with lower upfront costs. NuScale aims to make nuclear power more accessible for a broader range of electricity needs, potentially opening new markets for nuclear energy.
<h3>Centrus Energy&nbsp;</h3>
Centrus Energy&nbsp;(AMEX:LEU) isn&#39;t solely focused on reactor design but plays a crucial role in the nuclear fuel cycle. The company is developing advanced nuclear fuels explicitly designed for next-generation reactors. They&#39;ve also forged a significant partnership with TerraPower, a venture-backed by Bill Gates, to advance new reactor technologies. This partnership highlights Centrus&#39; importance in the broader scheme of nuclear innovation.
<h3>BWX Technologies&nbsp;</h3>
BWX Technologies (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bwxt#NYSE">BWXT</a>) has a strong legacy of providing components and services for the existing nuclear power industry. However, it is also looking ahead by actively developing microreactors. These ultra-small reactors hold the potential to provide energy in remote areas or to power specific applications like military bases. BWX&#39;s diversification across both current and future nuclear needs makes it a compelling company to add to your watchlist.
With their advancements, reactor developers have the potential to transform the nuclear power technology landscape. As they strive to make nuclear energy safer, more adaptable to diverse energy demands and scalable, these companies spearhead innovation. Although technological challenges remain, the triumphs of these pioneers could significantly expand nuclear energy&#39;s role in a future powered by clean energy.
<h2>Established Utilities with a Nuclear Advantage</h2>
Traditional energy utilities already heavily invested in nuclear power offer investors a unique way to participate in the sector. While new technologies are exciting, established utility companies with operational nuclear fleets provide exposure to a more established segment of the industry. Let&#39;s take a closer look at two major players:
<h3>Duke Energy&nbsp;</h3>
Duke Energy (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/duk#NYSE">DUK</a>) is a leading US utility company that boasts a substantial nuclear power fleet. This nuclear component complements its diverse portfolio, which also includes renewable energy sources and natural gas generation. For investors, Duke Energy offers a balance between the potential upside of the nuclear sector and the stability of a large, diversified utility company.
<h3>Exelon Corporation&nbsp;</h3>
Exelon Corporation&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) holds a dominant position as one of the largest operators of nuclear power plants in the United States. Unlike Duke, Exelon&#39;s power generation relies more heavily on nuclear facilities. This makes Exelon a more direct play on potential legislative or market changes that favor the nuclear energy industry and could lead to increased profitability for the company&#39;s nuclear segment.
Established utilities with significant nuclear operations provide a different investment opportunity than pure-play uranium miners or cutting-edge reactor developers. These utilities offer a way to benefit from a potential nuclear resurgence while also often maintaining a broader portfolio of energy assets that can provide some measure of stability. Investors will need to assess their risk tolerance and the role they envision nuclear stocks playing within their overall portfolio when considering companies like Duke Energy and Exelon.
<h2>Diversifying Nuclear Investment: The Role of ETFs</h2>
Exchange-traded funds (ETFs) provide investors a streamlined way to gain exposure to the nuclear energy sector without directly investing in individual companies. This basket approach can mitigate some risks associated with single stocks while allowing investors to benefit from the sector&#39;s potential growth. Here&#39;s a breakdown of two prominent ETFs in the nuclear space:
<h3>Global X Uranium ETF&nbsp;</h3>
The Global X Uranium ETF (ARCA:URA) is specifically designed to track companies involved in the mining and producing of uranium, along with businesses engaged in related stages of the nuclear fuel cycle. This ETF offers investors a more targeted way to bet on the rising demand for uranium if the resurgence of nuclear power comes to fruition.
<h3>VanEck Uranium+Nuclear Energy ETF</h3>
The VanEck Uranium+Nuclear Energy ETF (ARCA:NLR) adopts a slightly broader approach than the Global X Uranium ETF. While still capturing exposure to uranium-related companies, this ETF also includes companies engaged in constructing and operating nuclear power plants. This expanded focus could benefit if both uranium demand and positive sentiment towards atomic power generation increase in tandem.
Nuclear energy ETFs present an appealing option for investors seeking a convenient and diversified approach to the industry. These ETFs eliminate the need for extensive research into individual companies but still give investors access to the potential growth trajectory of the nuclear sector. Investors must carefully consider the specific holdings and management fees of any exchange-traded fund before investing.
<h2>Policy and Regulation: The X-Factor</h2>
Government policies and regulations are pivotal in shaping the nuclear energy landscape. Favorable policies, like tax incentives or streamlined development processes, could ignite the sector, while restrictive regulations could hamper its growth. Investors need to keep a close eye on the evolving regulatory environment, as policies can greatly influence the prospects for nuclear-related investments.
<h2>Nuclear Power in A Global Context</h2>
Developing economies with booming energy needs could turn to nuclear power as a solution to reduce reliance on fossil fuels and address growing energy security concerns. China and India, for instance, already have ambitious nuclear power expansion plans. This global trend underscores the long-term potential for the nuclear sector and its associated stocks.
<h2>Challenges and Considerations: The Other Side of the Equation</h2>
Acknowledging the challenges and potential risks associated with nuclear power before making any investment decisions is essential. These include:
<ul>
<li>Waste Disposal: The safe and long-term storage of radioactive waste remains a contentious issue. While technological advancements offer potential solutions, this remains a concern for investors and the communities surrounding nuclear plants.</li>
<li>Risk of Accidents: Though safety standards have significantly improved, the potential for accidents, however rare, can generate public fear and negatively impact nuclear investments.</li>
<li>Long Development Timelines: Constructing new nuclear power plants can be lengthy and capital-intensive, making investment returns less immediate than other energy sectors.</li>
</ul>
Nuclear energy stocks have the potential to be lucrative investments in the long term, particularly if the growing need for reliable, low-carbon energy outweighs the industry&#39;s concerns and challenges. Nuclear technology isn&#39;t a silver bullet, but it can play a significant role in the diverse energy mix required for a sustainable future. While nuclear may not fully eclipse solar and wind power, the unique advantages of atomic energy may prove essential on the path toward a cleaner energy future.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/why-these-nuclear-stocks-could-beat-solar-and-wind-energy-stocks/">Why These Nuclear Stocks Could Beat Solar and Wind Energy Stocks</a>&quot; first appeared on MarketBeat.

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.
Shares of Micron Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mu#NASDAQ">MU</a>) rose sharply during Monday&rsquo;s session after B of A Securities maintained a Buy rating on the stock and raised its <a href="https://www.benzinga.com/quote/MU/analyst-ratings">price target from $120 to $144</a>.
Micron Technology shares climbed 6.6% to $125.69 on Monday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Doma Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/doma#NYSE">DOMA</a>) shares rose 34% to $6.08 after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 22.4% to $6.13 after the FDA earlier in the week informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L.</li>
<li>SolarMax Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smxt#NASDAQ">SMXT</a>) rose 22.1% to $11.18.</li>
<li>Ouster, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oust#NYSE">OUST</a>) shares jumped 19.8% to $9.51.</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) gained 17.2% to $4.09.</li>
<li>Ballard Power Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bldp#NASDAQ">BLDP</a>) gained 16.4% to $3.2350 after the company announced the signing of a Long Term Supply Agreement with Solaris for the supply of 1,000 hydrogen fuel cell engines for the European transit bus market.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) climbed 16% to $6.26. Cantor Fitzgerald analyst Josh Siegler reiterated Iris Energy with an Overweight and maintained a $10 price target.</li>
<li>Allego N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allg#NASDAQ">ALLG</a>) gained 15.2% to $1.67.</li>
<li>GigaCloud Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gct#NASDAQ">GCT</a>) rose 13.3% to $30.26.</li>
<li>ZimVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zimv#NASDAQ">ZIMV</a>) gained 12.6% to $18.56. ZimVie announced closing of sale of spine business to an affiliate of H.I.G. Capital for $375 million in total consideration.</li>
<li>DouYu International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/doyu#NASDAQ">DOYU</a>) gained 12% to $7.38.</li>
<li>COMPASS Pathways plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmps#NASDAQ">CMPS</a>) gained 10.6% to $9.20. Morgan Stanley analyst Vikram Purohit initiated coverage on Compass Pathways with an Overweight rating and announced a price target of $30.</li>
<li>Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) rose 9.6% to $4.1350 amid strength in precious metals stocks as gold rises on rate cut hopes.</li>
<li>Trip.com Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcom#NASDAQ">TCOM</a>) climbed 7.6% to $47.24. Citigroup analyst Brian Gong maintained Trip.com Group with a Buy and raised the price target from $53 to $55.</li>
<li>NexGen Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) gained 7% to $8.31.</li>
<li>Western Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wdc#NASDAQ">WDC</a>) rose 5.7% to $72.13.</li>
<li>The Chemours Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>) gained 6.4% to $27.94. Chemours recently said it identified four material weaknesses amid its internal control over financial reporting.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38024169/insiders-buying-outlook-therapeutics-and-2-other-stocks"> Insiders Buying Outlook Therapeutics And 2 Other Stocks</a>

WIIM

Shares of uranium stocks are trading higher following a report suggesting US oil companies are looking to use small nuclear reactors to power drilling operations in the Permian Basin.

NexGen Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>) reported its Q4 earnings results on Thursday, March 7, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
NexGen Energy missed estimated earnings by -100.0%, reporting an EPS of $-0.06 versus an estimate of $-0.03.
Revenue was down $0 from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.06 which was followed by a 5.0% drop in the share price the next day.

To track all earnings releases for NexGen Energy <a href="https://www.benzinga.com/quote/NXE/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

NexGen Energy: Q4 Earnings Insights

The uranium mining industry is experiencing a notable resurgence. Prices for nuclear fuel soar, prompting the revival of <a href="https://www.benzinga.com/topic/mining">once-forgotten mines</a>. 
As governments increasingly reconsider nuclear energy as a solution to growing climate change concerns, the prices have surged, creating opportunities for previously unprofitable mines to <a href="https://www.benzinga.com/news/earnings/24/02/37341727/energy-fuels-ramps-up-colorado-and-wyoming-mines-to-skyrocket-uranium-production">fill a growing supply gap</a>.
Now Read: <a href="https://www.benzinga.com/markets/commodities/24/02/37394599/largest-global-miner-announces-restructuring-as-profit-hits-an-8-year-low">Largest Global Miner Announces Restructuring As Pro</a><a href="https://www.benzinga.com/markets/commodities/24/02/37394599/largest-global-miner-announces-restructuring-as-profit-hits-an-8-year-low">fit Hits An 8-Year Low</a>
Canada, for example, has attracted <a href="https://www.benzinga.com/news/24/01/36836481/surging-uranium-demand-supply-constraints-fuel-predictions-of-record-price-increases">increased exploration and mining activities</a>. Cameco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) is increasing production and extending the life of its Cigar Lake mine. It&#8217;s also exploring options to expand production capacity at its McArthur River/Key Lake mine. 
Furthermore, Denison Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DNN#AMEX">DNN</a>) has <a href="https://www.benzinga.com/news/24/01/36781665/uranium-revival-denison-mines-resumes-operations-at-mcclean-lake-as-prices-soar">restarted uranium mining</a> operations at its McClean Lake joint venture with Orano Canada Inc.
The Canadian market has also seen a heightened capex activity and a surge in mergers and acquisitions:
NexGen Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>), which owns exploration properties in Saskatchewan, updated its expanded at-the-market equity offering to sell up to $368 million (CA$500 million) of common shares from treasury, reflecting its commitment to advancing the<a href="https://www.nexgenenergy.ca/rook-1-project/"> Rook I project</a>, the largest development-stage uranium project in Canada.
<ul>
<li>92 Energy (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/NTELF#OTCQX">NTELF</a>), an Australian developer of Canadian uranium properties, proposed <a href="https://www.benzinga.com/markets/commodities/24/02/37126360/with-two-key-acquisitions-atha-energy-corp-emerges-as-a-premier-uranium-exploration-company">three-way merger acquisition</a> of ATHA Energy (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/SASKF#OTCQB">SASKF</a>) and Latitude Uranium (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/LURAF#OTCQB">LURAF</a>).</li>
<li>IsoEnergy (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ISENF#OTCQX">ISENF</a>) <a href="https://www.benzinga.com/pressreleases/23/11/g35722648/leading-proxy-advisory-firm-iss-recommends-consolidated-uranium-shareholders-vote-for-the-arrangem">merged</a> with Consolidated Uranium (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURUF#OTC">CURUF</a>), enhancing its portfolio and expanding its exploration activities in the Athabasca Basin in Saskatchewan and Quebec properties.</li>
<li>IsoEnergy also completed a $23 million private placement deal in February. It intends to utilize the proceeds to explore its Athabasca Basin Portfolio and Quebec properties.</li>
<li>Fission Uranium Corporation (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/FCUUF#OTCQX">FCUUF</a>) announced a <a href="https://www.benzinga.com/news/24/02/36968704/fission-uranium-announces-funding-for-uranium-project-in-saskatchewan">$75 million offering</a>, earmarking the proceeds for the exploration and development of its PLS uranium project in the Athabasca Basin in Saskatchewan.</li>
</ul>
Meanwhile, at least five U.S. producers are restarting operations in states such as Wyoming, Texas, Arizona, and Utah. Production had previously thrived until the aftermath of the 2011 Fukushima nuclear disaster in Japan.
The U.S. resurgence is also politically motivated, as heightened geopolitical uncertainty creates issues securing uranium shipments from Kazakhstan. This former Soviet state is the largest global uranium producer, and it typically exports commodities through Russian ports.
If the U.S. continues on the planned uranium consumption trajectory, the Uranium Producers of America <a href="https://www.bloomberg.com/news/articles/2024-03-03/uranium-firms-revive-forgotten-mines-as-price-of-nuclear-fuel-soars">forecasts</a> a need for eight to 10 new mines. 
American uranium production bottomed in 2019 at an all-time low of 174,000 pounds. That&#8217;s in stark contrast from the peak of 44 million pounds in 1980.
Retail investors in Uranium will keep Sprott Physical Uranium Trust (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SRUUF#OTC">SRUUF</a>) on their watchlist as this Toronto-based holding company invests nearly all of its assets in uranium.
See Also: <a href="https://www.benzinga.com/news/large-cap/24/02/37287732/gold-miner-newmont-looks-to-sell-assets-reduce-8b-debt-load">Gold Miner Newmont Looks To Sell Assets, Reduce $8B Debt Load</a>
Image: Shutterstock

UROY

Shares of uranium stocks are trading higher after miner Kazatomprom reportedly said it is likely to experience a production shortfall, which has weighed on supply outlook.

U.S. stock futures were mixed this morning, with the Dow futures gaining around 50 points on Friday.
Shares of Flexsteel Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flxs#NASDAQ">FLXS</a>) rose sharply in today&rsquo;s pre-market trading after the company reported strong preliminary <a href="https://www.benzinga.com/quote/FLXS/news">results for the second quarter</a>.
The company said it sees preliminary earnings of 57 cents per share, versus analysts&rsquo; estimates of 27 cents per share. The company sees revenue of $100.1 million versus expectations of $96.77 million. Flexsteel Industries also issued financial guidance for the remainder of fiscal year 2024 and fiscal year 2025.
Flexsteel Industries shares jumped 26.8% to $22.87 in pre-market trading.
Here are some big stocks recording gains in today&rsquo;s pre-market trading session.
<ul>
<li>Sify Technologies Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sify#NASDAQ">SIFY</a>) shares rose 6.9% to $1.86 in pre-market trading. Sify Technologies is expected to report its unaudited IFRS financial results for the third quarter ended Dec. 31, 2023 before the opening bell on Jan. 18, 2024.</li>
<li>Arcutis Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arqt#NASDAQ">ARQT</a>) climbed 5.4% to $3.90 in pre-market trading after falling over 10% on Thursday. Arcutis Canada recently announced Health Canada acceptance of the supplement to a new drug submission for Roflumilast Foam 0.3% for seborrheic dermatitis in individuals 9 years of age and older.</li>
<li>Nordic American Tankers Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nat#NYSE">NAT</a>) shares gained 5.3% to $4.58 in pre-market trading.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dna#NYSE">DNA</a>) gained 4.4% to $1.40 in pre-market trading after falling around 5% on Thursday. Ginkgo Bioworks recently said preliminary unaudited Cell Engineering revenue is expected to be within the previously disclosed guidance range of $145 &ndash; $150 million in 2023.</li>
<li>NexGen Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) rose 4.7% to $7.38 in pre-market trading.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) rose 4.3% to $14.31 in pre-market trading after gaining over 6% on Thursday.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) gained 3.9% to $4.55 in pre-market trading.</li>
<li>Wipro Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wit#NYSE">WIT</a>) gained 3% to $5.53 in pre-market trading ahead of quarterly results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/01/36606238/citigroup-bank-of-america-and-3-stocks-to-watch-heading-into-friday"> Citigroup, Bank of America And 3 Stocks To Watch Heading Into Friday </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Pre-Market Outlook

ARQT

FLXS

SIFY

Flexsteel Industries Posts Strong Preliminary Results, Joins Wipro, Sify Technologies And Other Big Stocks Moving Higher In Friday's Pre-Market Session

NexGen Energy Updated Its At-The-Market Equity Program To Offer And Sell Up To C$500M Of Common Shares From Treasury

NexGen Energy Ltd&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) reported Q2 FY23 EPS loss of C$(0.04)&nbsp;<a class="editor-rtfLink" href="https://s28.q4cdn.com/891672792/files/doc_financials/2023/q2/NexGen-Energy-MDA-Q2-2023_FINAL.pdf" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">vs. C$(0.02) a year ago</a>.
In USD terms, the company reported EPS of $(0.03), missing the&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/calendars/earnings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">consensus of $(0.01)</a>.
The company reported a net loss of C$(17.5) million vs. net income of C$17.6 million a year ago.
The company recognized a mark-to-market loss on the Convertible Debentures of C$2.7 million vs mark-to-market gain of C$28.5 million a year ago.
In Q2, operating cash outflow before working capital adjustments stood at C$(8.2) million.&nbsp;
As of June 30, 2023, the cash balance stood at C$100.6 million, and marketable securities at C$7.2 million.&nbsp;
In June, the company inked an Impact Benefit Agreement (IBA) with the M&eacute;tis Nation &ndash; Saskatchewan Northern Region 2 (MN-S NR2) and the M&eacute;tis Nation &ndash; Saskatchewan (MN-S) covering all phases of the Rook I Project.
Through 2023, the company plans to continue to advance the EA and licensing activities toward submitting the final EIS and licensing application to get a Uranium Mine and Mill License from the CNSC and continue engagement with Provincial and Federal regulators and communities.
Price Action: NXE shares are trading lower by 0.51% at $4.87 on the last check Wednesday.

Equities

Mid Cap

NexGen Energy Registers C$17.5M Loss In Q2

NexGen Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.01) by 200 percent. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year.

NexGen Energy Q2 EPS $(0.03) Misses $(0.01) Estimate

NexGen Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>) is set to give its latest quarterly earnings report on Wednesday, 2023-08-09. Here's what investors need to know before the announcement.
Analysts estimate that NexGen Energy will report an earnings per share (EPS) of $-0.01. 
NexGen Energy bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here's a look at NexGen Energy's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td></td>
<td>-0.01</td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.01</td>
<td>-0.04</td>
<td>-0.04</td>
<td>-0.02</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.28%</td>
<td>-1.68%</td>
<td>0.86%</td>
<td>0.84%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of NexGen Energy were trading at $4.91 as of August 07. Over the last 52-week period, shares are up 14.58%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/NXE/earnings">To track all earnings releases for NexGen Energy visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For NexGen Energy

Rumors

Analyst Ratings

Watching Nexgen Energy Ltd.; Hearing Zacks Under $10 Newsletter Picks Stock

In response to the passage of nuclear power legislation, the stock prices of uranium exploration, extraction, and processing companies <a href="http://www.benzinga.com/money/best-uranium-stocks">have been rising&nbsp;sharply.</a>
The Global X Uranium ETF (ARCA: URA) has skyrocketed by 10% over the past three trading sessions, as the U.S. government intends to increase investments in the industry in the upcoming years.
What happened: On June 1, the Senate Environment and Public Works (EPW) Committee enacted the bipartisan ADVANCE Act, a nuclear energy bill intended to position the United States as a global leader in nuclear technology and energy.
The legislation, introduced by Ranking Member Sen.&nbsp;Shelley Moore Capito (R-WV), Chairman Sen.&nbsp;Tom Carper (D-DE), Sen.&nbsp;Sheldon Whitehouse (D-RI), aims to encourage the development and deployment of novel nuclear technologies.
Also Read:&nbsp;<a href="https://www.benzinga.com/news/23/06/32684751/these-senators-voted-against-debt-ceiling-bill-as-biden-says-i-look-forward-to-signing-it-into-law">These Senators Voted Against Debt Ceiling Bill As Biden Says &#39;I Look Forward To Signing&#39; It Into Law</a>
Why it matters: The ADVANCE Act has the potential to promote market growth and performance in the nuclear energy sector, as it provides the Nuclear Regulatory Commission (NRC) with the tools and resources necessary to facilitate the safe and competitive development of nuclear technology in the United States.
It will reduce regulatory costs, incentivize next-generation reactors, and streamline the licensing procedure for nuclear facilities on brownfield sites.
Capito stated, &quot;From both a national security and energy independence standpoint, the United States has everything to gain by becoming the world leader in nuclear energy, and today we took an important step toward achieving that goal.&quot;
Market Reactions:&nbsp;
<ul>
<li>Cameco Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccj#NYSE">CCJ</a>) the largest company in the uranium industry with a 25% weight in the Global X Uranium ETF, rose 14% since Wednesday, May 31.</li>
<li>Nextgen Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) has gained 21% over the same time frame.</li>
<li>Uranium Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uec#NYSE">UEC</a>) soared 22%.</li>
<li>Energy Fuels Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uuuu#NYSE">UUUU</a>) is up 11.5%.</li>
<li>Denilson Mines Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dnn#NYSE">DNN</a>) surged 12%.</li>
</ul>
Chart To Watch: Uranium Stocks Rallied Following ADVANCE Act Approval
<img alt="" src="https://www.benzinga.com/files/u1363475/ura_2023-06-02_17-07-25_a208d.png" style="height:500px; width:100%" />
Now Read:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/23/06/32692690/new-drug-based-on-fda-approved-synthetic-thc-and-cannamide-shows-promise-in-treating-agitation-i" target="_blank">New Drug Based On FDA-Approved Synthetic THC And CannAmide Shows Promise In Treating Agitation In Alzhemier&#39;s</a>
Photo: Unspalsh

Government

Long Ideas

Regulations

Sector ETFs

Specialty ETFs

New ETFs

Politics

Small Business

General

Bullish On Uranium: Senate-Approved Nuclear Energy Bill Fuels Rally In Stocks And ETFs

U.S. stocks traded mostly lower, with the Dow Jones dropping over 100 points on Thursday. Here are some big stocks recording gains in today&rsquo;s session.
<ul>
<li>QuantaSing Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qsg#NASDAQ">QSG</a>) rose 30.8% to $11.24 after the company reported third-quarter financial results and issued guidance.</li>
<li>Chewy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>) shares jumped 24.2% to $36.62 after the company reported a year-over-year increase in first-quarter EPS results and better-than-expected sales results.</li>
<li>Lands&#39; End, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/le#NASDAQ">LE</a>) gained 23.1% to $7.72 following upbeat first-quarter results.</li>
<li>Pure Storage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pstg#NYSE">PSTG</a>) rose 16% to $33.43 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) shares surged 14.6% to $5.11. The China-based technology firm recently reported a first-quarter FY23 revenue of $271.48 million, missing the consensus of $282.80 million.</li>
<li>Veeva Systems Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/veev#NYSE">VEEV</a>) gained 12.8% to $186.93 after the company reported better-than-expected first-quarter results and issued strong EPS guidance.</li>
<li>Credo Technology Group Holding Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdo#NASDAQ">CRDO</a>) surged 11.5% to $14.97 following upbeat quarterly sales.</li>
<li>Uranium Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uec#NYSE">UEC</a>) rose 10% to $2.85.</li>
<li>Alteryx, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ayx#NYSE">AYX</a>) gained 9.8% to $42.77. B of A Securities upgraded Alteryx from Neutral to Buy and raised the price target from $60 to $70.</li>
<li>OraSure Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osur#NASDAQ">OSUR</a>) climbed 9.5% to $5.51.</li>
<li>Frontline plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fro#NYSE">FRO</a>) gained 9.4% to $15.46.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) surged 9.4% to $36.13. Aehr Test Systems reported new customer and initial order for FOX-XP multi-wafer test and burn-in system for volume production of silicon carbide MOSFETs.</li>
<li>NexGen Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) gained 9.3% to $4.22.</li>
<li>Opera Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opra#NASDAQ">OPRA</a>) gained 8.9% to $17.15. TD Cowen maintained Opera with an Outperform and raised the price target from $14 to $19.</li>
<li>DHT Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dht#NYSE">DHT</a>) rose 7.8% to $8.29. DHT Holdings reported acquisition of 2018 built VLCC for $94.5 million.</li>
<li>NetApp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntap#NASDAQ">NTAP</a>) gained 7.8% to $71.52 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>Hormel Foods Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrl#NYSE">HRL</a>) climbed 7% to $40.91 following second-quarter results.</li>
</ul>

&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/05/32648869/dow-tumbles-over-200-points-chicago-pmi-drops-in-may"> Dow Tumbles Over 200 Points; Chicago PMI Drops In May</a>

AEHR

CHWY

CRDO

NTAP

OPRA

OSUR

PSTG

VEEV

NetApp, Hormel Foods, Pure Storage And Other Big Stocks Moving Higher On Thursday

NexGen Energy Reports Establishment Of 100% Indigenous Owned And Operated Gravel Supply Company In Northwest Saskatchewan

NexGen Announces Expanded 2023 Exploration Program

Offerings

NexGen Establishes C$250M At-the-Market Equity Program

<h3>Gainers</h3>
<ul>
<li>American Virtual Cloud Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avct#NASDAQ">AVCT</a>) climbed 156.3% to close at $0.3750 on Monday. American Virtual Cloud Technologies shares gained around 8% on Friday after the company announced changes to its board of directors and management team, along with the launch of a review to explore the sale of the entire business or selected assets.</li>
<li>Advanced Human Imaging Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ahi#NASDAQ">AHI</a>) shares surged 94.1% to close at $1.32 on Monday. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health O&Uuml;.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) shares jumped 81.8% to close at $5.00 on Monday. Sentage Holdings, last month, reported FY21 operating revenue of $2.26 million.</li>
<li>Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) jumped 55.6% to close at $2.38.</li>
<li>Netcapital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncpl#NASDAQ">NCPL</a>) jumped 34% to close at $4.26.</li>
<li>Sonendo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sonx#NYSE">SONX</a>) gained 28.6% to settle at $1.18. Sonendo recently posted a Q2 loss of $0.57 per share.</li>
<li>Bed Bath &amp; Beyond Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbby#NASDAQ">BBBY</a>) rose 24.8% to close at $13.35 amid the stock being a top mention by users on social media channels. The company is set to provide a strategic update this week after GameStop Corp chair Ryan Cohen sold his stake in the struggling retailer earlier this month.</li>
<li>TDH Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/petz#NASDAQ">PETZ</a>) gained 24.4% to settle at $3.72. The company recently announced it acquired all of the equity interest of Beijing Wenxin Company from Kargo Services.</li>
<li>TuanChe Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tc#NASDAQ">TC</a>) climbed 23% to settle at $3.10.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) rose 21.6% to close at $3.21.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stbx#NASDAQ">STBX</a>) gained 21.1% to close at $6.44 after dropping 25% on Friday.</li>
<li>Hill International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hil#NYSE">HIL</a>) jumped 20.4% to close at $3.37 following an updated merger agreement with Global Infrastructure Solutions which offers Hill shareholders $3.40 per share in cash versus $2.85 per share offered previously.</li>
<li>mCloud Technologies Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcld#NASDAQ">MCLD</a>) gained 18.6% to settle at $2.3595.</li>
<li>The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) climbed 18.3% to close at $2.00 after jumping 43% on Friday. OLB Group recently posted 1H sales of $17.16 million.</li>
<li>Centrus Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/leu#NYSE">LEU</a>) gained 17.2% to settle at $50.54.</li>
<li>Calithera Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cala#NASDAQ">CALA</a>) gained 17.1% to close at $3.83 after HC Wainwright &amp; Co. upgraded the stock from Neutral to Buy and announced a price target of $8.</li>
<li>CF Acquisition Corp. VI (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfvi#NASDAQ">CFVI</a>) rose 17% to close at $11.79.</li>
<li>Grindrod Shipping Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grin#NASDAQ">GRIN</a>) climbed 16.7% to close at $23.93 after Taylor Maritime delivered a non-binding proposal to acquire the company for $26 per share.</li>
<li>Aeglea BioTherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agle#NASDAQ">AGLE</a>) rose 16.7% to settle at $0.6047.</li>
<li>Aeglea BioTherapeutics announced presentations at the Society for the Study of Inborn Errors of Metabolism on August 31.</li>
<li>Locafy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcfy#NASDAQ">LCFY</a>) gained 16.6% to close at $0.73.</li>
<li>Bright Minds Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drug#NASDAQ">DRUG</a>) shares gained 15.7% to close at $2.95 after declining around 12% on Friday.</li>
<li>China Automotive Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caas#NASDAQ">CAAS</a>) gained 15.6% to close at $4.01.</li>
<li>Pinduoduo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pdd#NASDAQ">PDD</a>) shares climbed 14.7% to close at $66.04 after the company reported better-than-expected Q2 revenue results.</li>
<li>Minerva Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nerv#NASDAQ">NERV</a>) gained 12.9% to close at $11.66. Point72 Asset Management recently reported an 8.8% passive stake in the company.</li>
<li>NeuroOne Medical Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmtc#NASDAQ">NMTC</a>) gained 10.1% to close at $1.97. NeuroOne Medical Tech recently posted a quarterly loss of $0.17 per share.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) gained 9.7% to settle at $6.57.</li>
<li>Vinco Ventures, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbig#NASDAQ">BBIG</a>) rose 9.6% to close at $1.06. Vinco Ventures appointed Ross Miller as co-Chief Executive Officer along with John Colucci and Lisa King, effective immediately.</li>
<li>Cameco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccj#NYSE">CCJ</a>) gained 9.3% to close at $29.14. Shares of several uranium companies traded higher as countries look for energy alternatives amid the global energy crisis.</li>
<li>NexGen Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) gained 8.3% to close at $4.43.</li>
<li>Extreme Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/extr#NASDAQ">EXTR</a>) rose 8% to settle at $15.35.</li>
<li>Chimerix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmrx#NASDAQ">CMRX</a>) rose 7.9% to close at $2.33 after the company won a Department of Health and Human Services contract worth $126.9 million.</li>
<li>Civitas Resources, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/civi#NYSE">CIVI</a>) gained 5.8% to settle at $71.02. Shares of energy companies traded higher amid an increase in oil prices as Saudi Arabia raised the possibility that OPEC+ could make output cuts to support prices. Also, conflict in Libya impacted oil prices, as well.</li>
</ul>
&nbsp;
&nbsp;
<h3>Losers</h3>
<ul>
<li>Jianzhi Education Technology Group Company Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jz#NASDAQ">JZ</a>) shares tumbled 55.4% to close at $8.37 on Monday.</li>
<li>Azure Power Global Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/azre#NYSE">AZRE</a>) declined 44.1% to close at $5.85 after the company announced the resignation of Harsh Shah as CEO.</li>
<li>Cabaletta Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caba#NASDAQ">CABA</a>) fell 34% to settle at $1.2550. The company announced it will present data from its DesCAARTes trial at the European Academy of Dermatology and Venereology Congress on September 10, 2022.</li>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) dipped 31% to close at $1.85.</li>
<li>PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) dipped 25.7% to close at $3.65. PaxMedica priced its initial public offering of 1.55 million shares of common stock at $5.25 per share.</li>
<li>Getty Images Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gety#NYSE">GETY</a>) fell 25.2% to close at $20.15. Getty Images Holdings recently said it had set aside an additional $25 million of balance sheet cash for the previously announced $275 million of deal proceeds towards debt repayment.</li>
<li>Clarus Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crxt#NASDAQ">CRXT</a>) shares dipped 23% to close at $0.1570. Clarus Therapeutics recently reported its Q2 earnings results and announced it will be reducing approximately 40% of its staff in August 2022.</li>
<li>SelectQuote, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slqt#NYSE">SLQT</a>) dropped 22.7% to settle at $1.40 after the company reported a decline in Q4 sales results and issued FY23 sales guidance below analyst estimates.</li>
<li>Absci Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/absi#NASDAQ">ABSI</a>) fell 21.1% to close at $3.30.</li>
<li>Hall of Fame Resort &amp; Entertainment Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hofv#NASDAQ">HOFV</a>) declined 20.4% to close at $0.7959.</li>
<li>Entrada Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trda#NASDAQ">TRDA</a>) dropped 19.3% to settle at $11.75. Entrada Therapeutics recently posted a Q2 loss of $0.74 per share.</li>
<li>ZeroFox Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zfox#NASDAQ">ZFOX</a>) fell 17.6% to close at $6.60.</li>
<li>Mobilicom Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mob#NASDAQ">MOB</a>) fell 17% to close at $2.7399 after dipping around 40% on Friday. The company recently priced its IPO at $$4.13 per unit.</li>
<li>Akoya Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akya#NASDAQ">AKYA</a>) dropped 16.5% to settle at $11.63.</li>
<li>Akoya Biosciences recently posted a Q2 loss of $0.47 per share.</li>
<li>AMTD Digital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hkd#NYSE">HKD</a>) fell 16.1% to close at $138.50.</li>
<li>Clarus Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clar#NASDAQ">CLAR</a>) dipped 15.8% to settle at $18.78.</li>
<li>Hudson Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hdsn#NASDAQ">HDSN</a>) declined 14.8% to close at $8.93.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) fell 14.8% to close at $0.5454.</li>
<li>Tellurian Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tell#NYSE">TELL</a>) fell 14.4% to close at $3.85 after the company announced plans to issue units consisting of senior debt and warrants to buy shares of common stock.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) declined 14.3% to close at $3.97.</li>
<li>Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) fell 14.1% to close at $10.33. Farfetch recently reported better-than-expected Q2 adjusted EPS and sales results.</li>
<li>D-Wave Quantum Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qbts#NYSE">QBTS</a>) dropped 14.1% to settle at $7.80. D-Wave Quantum recently posted a Q2 loss of $0.12 per share.</li>
<li>Humanigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgen#NASDAQ">HGEN</a>) shares declined 13.7% to close at $0.2422. Humanigen, said on August 24, 2022, that it received notice of delisting or failure to satisfy a continued listing rule or standard from the Nasdaq.</li>
<li>Nerdy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrdy#NYSE">NRDY</a>) fell 13.4% to close at $3.05.</li>
<li>Aytu BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aytu#NASDAQ">AYTU</a>) fell 12.7% to close at $0.2330. Aytu BioPharma recently announced issuance of its first patent for AR101/Enzastaurin.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) dipped 10% to close at $12.44.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) fell 9.6% to settle at $58.65. The company recently posted upbeat quarterly results.</li>
<li>SAI.TECH Global Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sai#NASDAQ">SAI</a>) fell 8.9% to close at $5.65.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikt#NASDAQ">IKT</a>) fell 8.5% to close at $0.8823. Inhibikase Therapeutics shares gained around 10% on Friday after the company announced that the FDA has reviewed its Investigational New Drug application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia and issued a Study May Procced letter.</li>
<li>PagSeguro Digital Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pags#NASDAQ">PAGS</a>) fell 8% to settle at $15.36.</li>
<li>BeiGene, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgne#NASDAQ">BGNE</a>) declined 7.6% to settle at $167.30. BeiGene recently announced acceptance of 11th regulatory submission for PD-1 Inhibitor Tislelizumab in China.</li>
<li>Catalent, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctlt#NYSE">CTLT</a>) dropped 7.4% to close at $92.28 after the company said it expects 2023 revenue to be lower than analysts anticipated.</li>
<li>Tuesday Morning Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tuem#NASDAQ">TUEM</a>) fell 7.4% to close at $0.3201 after declining around 7% on Friday.</li>
<li>EQRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eqrx#NASDAQ">EQRX</a>) fell 7.3% to settle at $4.60. EQRx recently posted a Q2 loss of $0.17 per share.</li>
<li>Kohl&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kss#NYSE">KSS</a>) dropped 5.6% to close at $28.09. Kohl&#39;s recently reported worse-than-expected Q2 EPS results and issued FY22 EPS guidance.</li>
<li>Apple Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) fell 1.4% to close at $161.38. Apple has long been rumored to be working on its Augmented Reality/Virtual Reality headset. The tech giant may want to have the right to use the term &ldquo;Reality&rdquo; for its mixed reality headset, Bloomberg reported, citing the company&rsquo;s trademark filings.</li>
</ul>

AAPL

ABSI

AGLE

AKYA

AVCT

AYTU

AZRE

BBBY

BBIG

BGNE

BIVI

BXRX

CAAS

CABA

CALA

CFVI

CIVI

CLAR

CMRX

CRXT

CTLT

DRUG

EQRX

EXTR

FTCH

GETY

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

HDSN

HGEN

HOFV

JFBR

LCFY

LIVN

LXEH

MCLD

NCPL

NERV

NMTC

NRDY

PAGS

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PETZ

PXMD

QBTS

SLQT

SNTG

SONX

STBX

TELL

TRDA

TUEM

ZFOX

Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Advanced Human Imaging Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ahi#NASDAQ">AHI</a>) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health O&Uuml;.</li>
<li>American Virtual Cloud Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avct#NASDAQ">AVCT</a>) rose 41.4% to $0.2068. American Virtual Cloud Technologies shares gained around 8% on Friday after the company announced changes to its board of directors and management team, along with the launch of a review to explore the sale of the entire business or selected assets.</li>
<li>Minerva Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nerv#NASDAQ">NERV</a>) jumped 25% to $12.96. Point72 Asset Management recently reported an 8.8% passive stake in the company.</li>
<li>Pinduoduo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pdd#NASDAQ">PDD</a>) shares gained 23.5% to $71.11 after the company reported better-than-expected Q2 revenue results.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stbx#NASDAQ">STBX</a>) rose 23.1% to $6.55 after dropping 25% on Friday.</li>
<li>The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) rose 20.1% to $2.03 after jumping 43% on Friday. OLB Group recently posted 1H sales of $17.16 million.</li>
<li>Hill International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hil#NYSE">HIL</a>) jumped 20% to $3.36 following an updated merger agreement with Global Infrastructure Solutions which offers Hill shareholders $3.40 per share in cash versus $2.85 per share offered previously.</li>
<li>Chimerix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmrx#NASDAQ">CMRX</a>) gained 19.4% to $2.58 after the company won a Department of Health and Human Services contract worth $126.9 million.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) shares climbed 17.8% to $3.24. Sentage Holdings, last month, reported FY21 operating revenue of $2.26 million.</li>
<li>NeuroOne Medical Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmtc#NASDAQ">NMTC</a>) climbed 15.5% to $2.07. NeuroOne Medical Tech recently posted a quarterly loss of $0.17 per share.</li>
<li>Bright Minds Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drug#NASDAQ">DRUG</a>) shares rose 14.9% to $2.93 after declining around 12% on Friday.</li>
<li>Grindrod Shipping Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grin#NASDAQ">GRIN</a>) gained 14.9% to $23.55 after Taylor Maritime delivered a non-binding proposal to acquire the company for $26 per share.</li>
<li>China Automotive Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caas#NASDAQ">CAAS</a>) jumped 14.4% to $3.97.</li>
<li>Netcapital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncpl#NASDAQ">NCPL</a>) gained 12.2% to $3.5680.</li>
<li>Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) gained 11.7% to $1.7087.</li>
<li>NexGen Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxe#NYSE">NXE</a>) gained 9.9% to $4.4950.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) jumped 9.7% to $6.57.</li>
<li>Cameco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccj#NYSE">CCJ</a>) gained 8% to $28.76. Shares of several uranium companies traded higher as countries look for energy alternatives amid the global energy crisis.</li>
<li>MINISO Group Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NASDAQ">MNSO</a>) rose 7.8% to $7.26. The company recently posted upbeat quarterly results.</li>
<li>Vinco Ventures, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbig#NASDAQ">BBIG</a>) rose 6.5% to $1.0299. Vinco Ventures appointed Ross Miller as co-Chief Executive Officer along with John Colucci and Lisa King, effective immediately.</li>
<li>JinkoSolar Holding Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jks#NYSE">JKS</a>) gained 5.5% to $63.06. Goldman Sachs maintained JinkoSolar with a Sell and raised the price target from $31 to $35. The company, on Friday, reported second-quarter FY22 revenue growth of 137.6% year-on-year to $2.81 billion, beating the consensus of $2.28 billion.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Jianzhi Education Technology Group Company Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jz#NASDAQ">JZ</a>) shares dipped 47.7% to $9.80.</li>
<li>Azure Power Global Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/azre#NYSE">AZRE</a>) fell 41.8% to $6.09 after the company announced the resignation of Harsh Shah as CEO.</li>
<li>Clarus Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crxt#NASDAQ">CRXT</a>) shares fell 27.8% to $0.1469. Clarus Therapeutics recently reported its Q2 earnings results and announced it will be reducing approximately 40% of its staff in August 2022.</li>
<li>PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) fell 23.6% to $3.75. PaxMedica priced its initial public offering of 1.55 million shares of common stock at $5.25 per share.</li>
<li>SelectQuote, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slqt#NYSE">SLQT</a>) dropped 22.7% to $1.40 after the company reported a decline in Q4 sales results and issued FY23 sales guidance below analyst estimates.</li>
<li>Hall of Fame Resort &amp; Entertainment Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hofv#NASDAQ">HOFV</a>) fell 20.5% to $0.7950.</li>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) fell 18.6% to $2.18.</li>
<li>Getty Images Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gety#NYSE">GETY</a>) declined 15.4% to $22.80. Getty Images Holdings recently said it had set aside an additional $25 million of balance sheet cash for the previously announced $275 million of deal proceeds towards debt repayment.</li>
<li>Vaccitech plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vacc#NASDAQ">VACC</a>) dipped 15% to $4.40.</li>
<li>Humanigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgen#NASDAQ">HGEN</a>) shares fell 14.9% to $0.2387. Humanigen, said on August 24, 2022, that it received notice of delisting or failure to satisfy a continued listing rule or standard from the Nasdaq.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) declined 14.7% to $3.95.</li>
<li>Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) fell 13.7% to $10.36. Farfetch recently reported better-than-expected Q2 adjusted EPS and sales results. A</li>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) dropped 13% to $3.15.</li>
<li>Hudson Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hdsn#NASDAQ">HDSN</a>) declined 13.1% to $9.11.</li>
<li>Tellurian Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tell#NYSE">TELL</a>) fell 12.9% to $3.9180 after the company announced plans to issue units consisting of senior debt and warrants to buy shares of common stock.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) fell 12.7% to $0.5583.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikt#NASDAQ">IKT</a>) dropped 12.5% to $0.84. Inhibikase Therapeutics shares gained around 10% on Friday after the company announced that the FDA has reviewed its Investigational New Drug application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia and issued a Study May Procced letter.</li>
<li>Mobilicom Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mob#NASDAQ">MOB</a>) fell 12.1% to $2.90 after dipping around 40% on Friday. The company recently priced its IPO at $$4.13 per unit.</li>
<li>Aytu BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aytu#NASDAQ">AYTU</a>) declined 11.3% to $0.2366. Aytu BioPharma recently announced issuance of its first patent for AR101/Enzastaurin.</li>
<li>Nerdy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrdy#NYSE">NRDY</a>) fell 11.1% to $3.1299.</li>
<li>SAI.TECH Global Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sai#NASDAQ">SAI</a>) dropped 10.8% to $5.53.</li>
<li>ZeroFox Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zfox#NASDAQ">ZFOX</a>) fell 10.7% to $7.15.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) declined 10.6% to $1.85. Ainos recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for treatment of mild symptoms related to COVID-19.</li>
<li>Rapid Micro Biosystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rpid#NASDAQ">RPID</a>) declined 10.5% to $3.25. Rapid Micro Biosystems recently posted a Q2 loss of $0.31 per share.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikt#NASDAQ">IKT</a>) dropped 10% to $0.8672. Inhibikase Therapeutics shares gained around 10% on Friday after the company announced that the FDA has reviewed its Investigational New Drug application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia and issued a Study May Procced letter.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) fell 10% to $12.44.</li>
<li>AMTD Digital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hkd#NYSE">HKD</a>) fell 9.1% to $150.01.</li>
<li>Catalent, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctlt#NYSE">CTLT</a>) dropped 8.1% to $91.60 after the company said it expects 2023 revenue to be lower than analysts anticipated.</li>
<li>VBI Vaccines Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vbiv#NASDAQ">VBIV</a>) fell 6.7% to $0.8771. VBI Vaccines said on August 26, 2022, that the company delivered written notices to Jefferies to terminate each of July 2022 sales agreement, September 2021 sales agreement, effective Aug. 26, 2022.</li>
<li>Tuesday Morning Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tuem#NASDAQ">TUEM</a>) fell 6.4% to $0.3237 after declining around 7% on Friday.</li>
<li>Tesla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) fell 2.2% to $281.80. Deutsche Bank maintained Tesla with a Buy, adjusted price target to $375 - 3-for-1 stock split.</li>
<li>Apple Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) fell 2.1% to $160.17. Apple has long been rumored to be working on its Augmented Reality/Virtual Reality headset. The tech giant may want to have the right to use the term &ldquo;Reality&rdquo; for its mixed reality headset, Bloomberg reported, citing the company&rsquo;s trademark filings.</li>
</ul>

AIMD

GBNH

MNSO

RPID

TSLA

VACC

VBIV

Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session

URNM

Shares of several uranium companies are trading higher as countries look for energy alternatives amid the global energy crisis. Reports suggest some Asia-Pacific countries are exploring alternate clean energy solutions and reconsidering their stances on nuclear energy.

NexGen Energy Ltd (NXE) leads the Uranium industry with an overall score of 69. NXE is up 102.34% so far this year after the company closed yesterday at $7.77.  The overall score measures the company's performance based-off both short and long term indicators and means that NXE scores better than 69% of the overall market.

Is NexGen Energy Ltd (NXE) the Top Pick in the Uranium Industry?

DWSN, INDO among major energy gainers; BORR, AMTX major losers

Commodity Roundup: ANZ keeps yr-end gold price target of $2,300; WTI futures top $85

Commodity Roundup: ANZ keeps yr-end gold PT of $2,300; WTI futures top $85

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The world is fighting to go green. So, it&rsquo;s a good idea to have exposure to&nbsp;some of the best renewable <a href="https://investorplace.com/industries/energy/">energy stocks</a> to buy in April.



For one,&nbsp;<a href="https://www.weforum.org/agenda/2024/02/renewables-energy-capacity-demand-growth/">according to the International Energy Agency</a>, renewable energy sources will account for over 42% of global electricity generation, with wind and solar doubling to 25%. In addition, the agency says the &ldquo;World added&nbsp;50% more renewable capacity in 2023 than in 2022 and next 5 years will see the fastest growth yet&hellip;&rdquo;



Two, when and if the Federal Reserve does cut interest rates, renewable energy projects could see further upside.&nbsp;Remember, when interest rates get too high, financing gets more expensive and margins suffer.



Three, for the world to meet the net-zero scenario,&nbsp;<a href="https://about.bnef.com/blog/global-clean-energy-investment-jumps-17-hits-1-8-trillion-in-2023-according-to-bloombergnef-report/">BloombergNEF says energy investments</a>&nbsp;would have to average about $4.7 trillion a year between now and 2030.&nbsp;



Helping, 116 countries recently signed the&nbsp;Global Renewables and Energy Efficiency Pledge. That pledge aims to &ldquo;triple global renewable generation capacity to at least 11,000 gigawatts and to double the global average annual rate of energy efficiency improvements from around 2% to more than 4% every year until 2030,&rdquo;&nbsp;<a href="https://www.edie.net/surging-renewables-growth-hindered-by-lack-of-finance-worldwide/#:~:text=A%20total%20of%20116%20countries,more%20than%204%25%20every%20year">as noted by Edie.net</a>.



That being said, I&rsquo;d start buying the&nbsp;best <a href="https://investorplace.com/industries/energy/renewable-energy/">renewable energy stocks</a> to buy in April.



<h2>NexGen Energy (NXE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/uranium1600-300x169.jpg" alt="periodic table concept with black cubes. uranium element is glowing. Uranium stocks"><div>Source: Shutterstock</div></div>With uranium prices still red-hot on supply-demand issues, consider&nbsp;NexGen Energy&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nxe-stock-quote/">NXE</a>) once it bottoms out again. After becoming overbought at $8.75, it&rsquo;s now back to $8.33, and could potentially retest support at its 50-day moving average.



Over the long-term, uranium demand&nbsp;is expected to jump 127% by 2030. By 2040, demand could be up by 200%, creating a potential 240-million-pound deficit. Worse, the deficit could continue to widen with growth in annual demand expected to triple by 2050,&nbsp;<a href="https://s28.q4cdn.com/891672792/files/doc_presentations/2024/NXE_CorpDeck_February-2024.pdf">as noted by the company</a>.



Plus, over the last few weeks, NXE just announced a&nbsp;<a href="https://www.tipranks.com/news/company-announcements/nexgen-energy-unveils-major-uranium-discovery">new uranium discovery at its SW2 Property</a>. According to&nbsp;<a href="https://www.canadianminingjournal.com/news/nexgen-finds-new-greenfield-uranium-mineralization-3-5-km-from-arrow-deposit/">company CEO Leigh Curyer</a>, &ldquo;This new intercept reflects the high potential of NexGen&rsquo;s extensive land package in the southwestern section of the Athabasca Basin, Saskatchewan.&nbsp;Drilling activity is being fully dedicated to this new discovery area to advance our understanding of scope and scale of mineralization.&rdquo;



Again, wait for NXE to pull back before buying.&nbsp;



<h2>Brookfield Renewable Energy (BEP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/bepc-1600-300x169.jpg" alt="A phone displaying the logo for Brookfield Renewable Corporation (BEPC)"><div>Source: Piotr Swat / Shutterstock</div></div>I&rsquo;d also take advantage of the recent weakness in&nbsp;Brookfield Renewable Energy&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/bep-stock-quote/">BEP</a>). It&rsquo;s another one of the&nbsp;best renewable energy stocks to buy in April.



For one, while we wait for it to recover, we can collect its current yield of 6.13%. It recently paid out a dividend of 35.5 cents per share, or about $1.42 annualized.&nbsp;



Two, its dividend is sustainable, with the company generating predictable cash flow. About&nbsp;<a href="https://bep.brookfield.com/press-releases/bep/brookfield-renewable-reports-record-results-and-announces-5-distribution">90% of its cash flow</a>is contracted under long-term, inflation-adjusted deals.



Three,&nbsp;<a href="https://bep.brookfield.com/press-releases/bep/brookfield-renewable-reports-record-results-and-announces-5-distribution">according to CEO Connor Teskey</a>, &ldquo;Going forward we are well positioned to continue benefiting from accelerating demand for clean power from corporate customers, and specifically the large global technology companies, whose increasing appetite for clean power is being driven by data center demand, with securing clean energy now squarely on their critical path to growth.&rdquo;



Plus, earnings have been solid. In its most recent quarter, the company&rsquo;s funds from operations came in at 38 cents, beating estimates by a penny. Revenue of $1.32 billion &mdash; up nearly 11% year over year &mdash; beat by $130 million.&nbsp;



<h2>Invesco Global Clean Energy ETF (PBD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/greenenergy1600-300x169.jpg" alt="Green energy stocks"><div>Source: Shutterstock</div></div>Or, if you prefer to diversify at a low cost of about $13.95, check out the Invesco&nbsp;Global Clean Energy ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/pbd-stock-quote/">PBD</a>). With an expense ratio of 0.75%, the ETF invests in stocks&nbsp;that focus on renewable sources of energy and technologies that help facilitate cleaner energy.&nbsp;



Some of its top holdings include&nbsp;Sunrun&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/run-stock-quote/">RUN</a>),&nbsp;Sunnova Energy&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nova-stock-quote/">NOVA</a>),&nbsp;Enphase Energy&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/enph-stock-quote/">ENPH</a>),&nbsp;FuelCell Energy&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/fcel-stock-quote/">FCEL</a>) and another 104 related holdings. What&rsquo;s nice about this ETF is we can gain exposure to 108 green stocks at less than $14 a share at the moment.&nbsp;



Eventually, when the Federal Reserve starts cutting rates, I&rsquo;d like to see the PBW ETF rally back to $31 initially. In the long term, I&rsquo;d like to see the ETF run back to $65, which it hit in mid-2022. But again, much of this depends on when and if the Federal Reserve cuts interest rates.



On the date of publication, Ian Cooper did not hold (either directly or indirectly) any positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>
<div>Ian Cooper, a contributor to InvestorPlace.com, has been analyzing stocks and options for web-based advisories since 1999.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/the-3-best-renewable-energy-stocks-to-buy-in-april-2024/">The 3 Best Renewable Energy Stocks to Buy in April 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The 3 Best Renewable Energy Stocks to Buy in April 2024

As we have been harping on for the last couple of years, uranium stocks are continuing their long-awaited ascent. The sector has experienced a significant boost, with spot prices surging 40% over the past year.

Goldman Offers "Burst Of Bullish Coverage" On Soaring Uranium Stocks

IsoEnergy: A High-Beta Uranium Developer With A Good Valuation

BROG, HUSA among major energy losers; NINE major gainer

NexGen Energy: Still A Long Way To Go For A Buy Rating

Raymond James analyst Brian MacArthur maintained a Buy rating on NexGen Energy (NXE – Research Report) today and set a price target of C$14.00. The...